In addition, MLT effectively reduced the abdominal tumor burden of ovarian cancer induced by CRS through inhibiting the NE/AKT/β-catenin/SLUG axis in nude mouse models and in vitro, suggesting a potential therapeutic relevance. This evidence concerns the gene AKT1 and ovarian carcinoma.